Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women()()

Access to safe and effective contraceptive choices is a reproductive right and contributes tremendously to improvements in maternal and child health. Progestin-only injectables, particularly intramuscularly injected depot medroxyprogesterone acetate (DMPA-IM), have received increased attention given...

Descripción completa

Detalles Bibliográficos
Autores principales: Heffron, Renee, Achilles, Sharon L., Dorflinger, Laneta J., Hapgood, Janet P., Kiarie, James, Polis, Chelsea B., Steyn, Petrus S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467541/
https://www.ncbi.nlm.nih.gov/pubmed/30576636
http://dx.doi.org/10.1016/j.contraception.2018.12.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467541/
https://www.ncbi.nlm.nih.gov/pubmed/30576636
http://dx.doi.org/10.1016/j.contraception.2018.12.001

Ejemplares similares